{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T15:38:46Z","timestamp":1790177926619,"version":"4.1.0"},"reference-count":83,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["AMR\/Adhoc\/301\/2022-ECD-II"],"award-info":[{"award-number":["AMR\/Adhoc\/301\/2022-ECD-II"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.ijbiomac.2023.128402","type":"journal-article","created":{"date-parts":[[2023,11,28]],"date-time":"2023-11-28T22:43:52Z","timestamp":1701211432000},"page":"128402","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"P2","title":["Schematic-portfolio of potent anti-microbial scaffolds targeting DNA gyrase: Unlocking ways to overcome resistance"],"prefix":"10.1016","volume":"256","author":[{"given":"Kakarla","family":"Pakeeraiah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suvadeep","family":"Mal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monalisa","family":"Mahapatra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suman Kumar","family":"Mekap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pratap Kumar","family":"Sahu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudhir Kumar","family":"Paidesetty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijbiomac.2023.128402_bb0005","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1146\/annurev.biochem.78.082907.145923","article-title":"Multidrug resistance in bacteria","volume":"78","author":"Hiroshi","year":"2009","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.ijbiomac.2023.128402_bb0010","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.3390\/antibiotics11081079","article-title":"Antibiotic resistance in bacteria\u2014a review","volume":"11","author":"Urban-Chmiel","year":"2022","journal-title":"Antibiotics"},{"key":"10.1016\/j.ijbiomac.2023.128402_bb0015","doi-asserted-by":"crossref","first-page":"32244","DOI":"10.1021\/acsomega.3c02563","article-title":"Overcoming mycobacterium tuberculosis drug resistance: novel medications and repositioning strategies","volume":"8","author":"Sachan","year":"2023","journal-title":"ACS Omega"},{"key":"10.1016\/j.ijbiomac.2023.128402_bb0020","doi-asserted-by":"crossref","first-page":"4","DOI":"10.4103\/ijcm.IJCM_217_18","article-title":"Antimicrobial resistance: progress in the decade since emergence of New Delhi metallo-\u03b2-lactamase in India","volume":"44","author":"Dixit","year":"2019","journal-title":"Indian J. Community Med."},{"key":"10.1016\/j.ijbiomac.2023.128402_bb0025","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.drup.2016.09.002","article-title":"The rapid spread of carbapenem-resistant Enterobacteriaceae","volume":"29","author":"Potter","year":"2016","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.ijbiomac.2023.128402_bb0030","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1080\/22221751.2020.1754133","article-title":"Colistin and its role in the era of antibiotic resistance: an extended review (2000-2019)","volume":"9","author":"Ahmed","year":"2020","journal-title":"Emerg. Microbes Infect."},{"key":"10.1016\/j.ijbiomac.2023.128402_bb0035","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.2217\/fmb.12.117","article-title":"Emergence of multidrug-resistant, extensively drug-resistant and untreatable gonorrhoea","volume":"7","author":"Unemo","year":"2012","journal-title":"Future Microbiol."},{"key":"10.1016\/j.ijbiomac.2023.128402_bb0040","author":"Centers for Disease Control and Prevention"},{"key":"10.1016\/j.ijbiomac.2023.128402_bb0045","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.ijbiomac.2021.03.119","article-title":"Synthesis and characterization of chitosan silver nanoparticle decorated with benzodioxane coupled piperazine as an effective anti-biofilm agent against MRSA: a validation of molecular docking and dynamics","volume":"181","author":"Karthik","year":"2021","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2023.128402_bb0050","doi-asserted-by":"crossref","first-page":"78","DOI":"10.4103\/lungindia.lungindia_98_17","article-title":"Multidrug-resistant tuberculosis\/rifampicin-resistant tuberculosis: principles of management","volume":"35","author":"Prasad","year":"2018","journal-title":"Lung India"},{"key":"10.1016\/j.ijbiomac.2023.128402_bb0055","doi-asserted-by":"crossref","first-page":"14414","DOI":"10.1038\/ncomms14414","article-title":"Sansanmycin natural product analogues as potent and selective anti-mycobacterials that inhibit lipid I biosynthesis","volume":"1","author":"Tran","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ijbiomac.2023.128402_bb0060","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.tim.2021.11.004","article-title":"Epulopiscium spp","volume":"30","author":"Angert","year":"2022","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.ijbiomac.2023.128402_bb0065","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1146\/annurev.biochem.70.1.369","article-title":"DNA topoisomerases: structure, function, and mechanism","volume":"70","author":"Champoux","year":"2001","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.ijbiomac.2023.128402_bb0070","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.chembiol.2010.04.012","article-title":"DNA topoisomerases and their poisoning by anticancer and antibacterial drugs","volume":"17","author":"Pommier","year":"2010","journal-title":"Chem. Biol."},{"key":"10.1016\/j.ijbiomac.2023.128402_bb0075","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.01330-23","article-title":"Exploration of the novel fluoroquinolones with high inhibitory effect against quinolone-resistant DNA gyrase of Salmonella Typhimurium","author":"Toyting","year":"2023","journal-title":"Microbiol. Spectr."},{"key":"10.1016\/j.ijbiomac.2023.128402_bb0080","doi-asserted-by":"crossref","first-page":"17221","DOI":"10.1021\/jacs.7b07736","article-title":"The antibiotic novobiocin binds and activates the ATPase that powers lipopolysaccharide transport","volume":"139","author":"May","year":"2017","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ijbiomac.2023.128402_bb0085","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1128\/AAC.49.3.1093-1100.2005","article-title":"Simocyclinone D8, an inhibitor of DNA gyrase with a novel mode of action","volume":"49","author":"Flatman","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijbiomac.2023.128402_bb0090","first-page":"10354","article-title":"DNA gyrase with a single catalytic tyrosine can catalyze DNA supercoiling by a nicking-closing mechanism","volume":"44","author":"Gubaev","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ijbiomac.2023.128402_bb0095","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1128\/AAC.33.2.131","article-title":"Structure-activity relationships of the fluoroquinolones","volume":"33","author":"Chu","year":"1989","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijbiomac.2023.128402_bb0100","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a025320","article-title":"Topoisomerase inhibitors: fluoroquinolone mechanisms of action and resistance","volume":"6","author":"Hooper","year":"2016","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.ijbiomac.2023.128402_bb0105","article-title":"Increased expression of efflux pump NorA drives the rapid evolutionary trajectory from tolerance to resistance against ciprofloxacin in Staphylococcus aureus","volume":"20","author":"Yu","year":"2022","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijbiomac.2023.128402_bb0110","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1089\/mdr.2013.0171","article-title":"Ofloxacin resistance in Mycobacterium tuberculosis is associated with efflux pump activity independent of resistance pattern and genotype","volume":"6","author":"Sun","year":"2014","journal-title":"Microb. Drug Resist."},{"key":"10.1016\/j.ijbiomac.2023.128402_bb0115","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1093\/jac\/dkl398","article-title":"High-level resistance to moxifloxacin and gatifloxacin associated with a novel mutation in gyrB in toxin-A-negative, toxin-B-positive Clostridium difficile","volume":"6","author":"Drudy","year":"2006","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ijbiomac.2023.128402_bb0120","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1128\/AAC.43.5.1177","article-title":"In vitro development of resistance to five quinolones and amoxicillin-clavulanate in Streptococcus pneumonia","volume":"5","author":"Davies","year":"1999","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijbiomac.2023.128402_bb0125","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1111\/j.1469-0691.1998.tb00684.x","article-title":"Structure of grepafloxacin relative to activity and safety profile","volume":"4","author":"Hooper","year":"1998","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.ijbiomac.2023.128402_bb0130","first-page":"765","article-title":"Review of nemonoxacin with special focus on clinical development","volume":"5","author":"Qin","year":"2014","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.ijbiomac.2023.128402_bb0135","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1016\/j.jmb.2014.02.017","article-title":"A new crystal structure of the bifunctional antibiotic simocyclinone D8 bound to DNA gyrase gives fresh insight into the mechanism of inhibition","volume":"10","author":"Hearnshaw","year":"2014","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.ijbiomac.2023.128402_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.104885","article-title":"Novel 1, 2, 4-oxadiazole-chalcone\/oxime hybrids as potential antibacterial DNA gyrase inhibitors: design, synthesis, ADMET prediction and molecular docking study","volume":"111","author":"Ibrahim","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ijbiomac.2023.128402_bb0145","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ijmyco.2015.02.002","article-title":"Benzothiazinone-piperazine derivatives as efficient Mycobacterium tuberculosis DNA gyrase inhibitors","volume":"2","author":"Chandran","year":"2015","journal-title":"Int. J. Mycobacteriol."},{"key":"10.1016\/j.ijbiomac.2023.128402_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2022.134049","article-title":"Novel fluoroquinolone hybrids as dual DNA gyrase and urease inhibitors with potential antibacterial activity: design, synthesis, and biological evaluation","volume":"1271","author":"Abdel-Aziz","year":"2023","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.ijbiomac.2023.128402_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112324","article-title":"Novel bacterial topoisomerase inhibitors derived from isomannide","volume":"199","author":"Okumu","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2023.128402_bb0160","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.ejmech.2019.02.004","article-title":"An optimised series of substituted N-phenylpyrrolamides as DNA gyrase B inhibitors","volume":"167","author":"Tiz","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2023.128402_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2022.133028","article-title":"Novel cyclohepta [b] thiophene derivative incorporating pyrimidine, pyridine, and chromene moiety as potential antimicrobial agents targeting DNA gyrase","author":"Fayed","year":"2022","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.ijbiomac.2023.128402_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2023.135190","article-title":"Design, synthesis, and in-silico study of chromen-sulfonamide congeners as potent anticancer and antimicrobial agents","volume":"1283","author":"Mahapatra","year":"2023","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.ijbiomac.2023.128402_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiolchem.2020.107224","article-title":"Design of (quinolin-4-ylthio) carboxylic acids as new Escherichia coli DNA gyrase B inhibitors: machine learning studies, molecular docking, synthesis and biological testing","volume":"85","author":"Metelytsia","year":"2020","journal-title":"Comput. Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2023.128402_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111977","article-title":"One-pot synthesis and molecular docking of some new spiropyranindol-2-one derivatives as immunomodulatory agents and in vitro antimicrobial potential with DNA gyrase inhibitor","volume":"188","author":"Salem","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2023.128402_bb0185","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.ejmech.2017.02.046","article-title":"Discovery of substituted oxadiazoles as a novel scaffold for DNA gyrase inhibitors","volume":"130","author":"Jakopin","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2023.128402_bb0190","article-title":"New s-Triazine\/Tetrazole conjugates as potent antifungal and antibacterial agents: design, molecular docking and mechanistic study","volume":"20221267","author":"Mekheimer","year":"2022","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.ijbiomac.2023.128402_bb0195","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1002\/jhet.3583","article-title":"Molecular docking study of newly synthesized thiopyrimidines as antimicrobial agents targeting DNA gyrase enzyme","volume":"56","author":"El-serwy","year":"2019","journal-title":"J. Heterocyclic Chem."},{"key":"10.1016\/j.ijbiomac.2023.128402_bb0200","doi-asserted-by":"crossref","first-page":"10341","DOI":"10.1016\/j.bioorg.2019.103411","article-title":"Synthesis of 1, 2, 4-triazolo [1, 5-a] pyrimidine derivatives: antimicrobial activity, DNA gyrase inhibition and molecular docking","volume":"94","author":"Abd El-Aleam","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ijbiomac.2023.128402_bb0205","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.ejmech.2018.10.031","article-title":"Design, synthesis and antitubercular activity of 4-alkoxy-triazoloquinolones able to inhibit the M. tuberculosis DNA gyrase","volume":"161","author":"Carta","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2023.128402_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.103619","article-title":"Design, synthesis, in vitro antimicrobial evaluation and molecular docking studies of indol-2-one tagged with morpholinosulfonyl moiety as DNA gyrase inhibitors","volume":"96","author":"Salem","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ijbiomac.2023.128402_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2020.115439","article-title":"Identification of an ethyl 5, 6-dihydropyrazolo [1, 5-c] quinazoline-1-carboxylate as a catalytic inhibitor of DNA gyrase","volume":"28","author":"Aguirre","year":"2020","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2023.128402_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.103373","article-title":"Novel 2-arylbenzothiazole DNA gyrase inhibitors: synthesis, antimicrobial evaluation, QSAR and molecular docking studies","volume":"93","author":"Ghannam","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ijbiomac.2023.128402_bb0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.103672","article-title":"Design, green one-pot synthesis and molecular docking study of novel N, N-bis (cyanoacetyl) hydrazines and bis-coumarins as effective inhibitors of DNA gyrase and topoisomerase IV","volume":"97","author":"Metwally","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ijbiomac.2023.128402_bb0230","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1002\/jhet.3851","article-title":"Synthesis and biological activities of nitro-hydroxy-phenylquinolines; validation of antibiotics effect over DNA gyrase inhibition and antimicrobial activity","volume":"57","author":"Bilavendran","year":"2020","journal-title":"J. Heterocyclic Chem."},{"key":"10.1016\/j.ijbiomac.2023.128402_bb0235","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.bioorg.2017.01.019","article-title":"Synthesis, antimicrobial, cytotoxic and E. coli DNA gyrase inhibitory activities of coumarinyl amino alcohols","volume":"71","author":"Singh","year":"2017","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ijbiomac.2023.128402_bb0240","doi-asserted-by":"crossref","first-page":"14271","DOI":"10.1021\/acssuschemeng.2c04388","article-title":"Synthesis of \u03b1, \u03b2-unsaturated ketones in water: the Claisen\u2013Schmidt condensation revisited","volume":"10","author":"Choudhury","year":"2022","journal-title":"ACS Sustain. Chem. Eng."},{"key":"10.1016\/j.ijbiomac.2023.128402_bb0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2022.117004","article-title":"New potent ciprofloxacin-uracil conjugates as DNA gyrase and topoisomerase IV inhibitors against methicillin-resistant Staphylococcus aureus","volume":"73","author":"Samir","year":"2022","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2023.128402_bb0250","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.bioorg.2018.08.031","article-title":"Synthesis, antimicrobial activity and molecular modeling study of 3-(5-amino-(2H)-1, 2, 4-triazol-3-yl]-naphthyridinones as potential DNA-gyrase inhibitors","volume":"81","author":"Mohamed","year":"2018","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ijbiomac.2023.128402_bb0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.103841","article-title":"Antimicrobial evaluation of thiadiazino and thiazolo quinoxaline hybrids as potential DNA gyrase inhibitors; design, synthesis, characterization and morphological studies","volume":"99","author":"Ammar","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ijbiomac.2023.128402_bb0260","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.molstruc.2018.04.010","article-title":"Synthesis, docking, QSAR, ADMET and antimicrobial evaluation of new quinoline-3-carbonitrile derivatives as potential DNA-gyrase inhibitors","volume":"1166","author":"El-Gamal","year":"2018","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.ijbiomac.2023.128402_bb0265","article-title":"Synthesis of novel 2-aminobenzothiazole derivatives as potential antimicrobial agents with dual DNA gyrase\/topoisomerase IV inhibition","author":"Ismail","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ijbiomac.2023.128402_bb0270","doi-asserted-by":"crossref","first-page":"124","DOI":"10.2174\/1568026618666180329115523","article-title":"Coumarin compounds in medicinal chemistry: some important examples from the last years","volume":"18","author":"Pereira","year":"2018","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2023.128402_bb0275","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1016\/j.procbio.2016.08.031","article-title":"Antibacterial efficacy of fractions and compounds from Indigofera barberi: identification of DNA gyrase B inhibitors through pharmacophore based virtual screening","volume":"51","author":"Bhaskar","year":"2016","journal-title":"Proc. Biochem."},{"key":"10.1016\/j.ijbiomac.2023.128402_bb0280","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.sajb.2019.11.010","article-title":"Bactericidal and antibiotic-modulation activities of methanol crude extracts of Ligustrum lucidum and Lobelia inflata against MRSA phenotypes: molecular docking studies of some isolated compounds from both plants against DNA gyrase","volume":"130","author":"Oyedemi","year":"2020","journal-title":"S. Afr. J. Bot."},{"key":"10.1016\/j.ijbiomac.2023.128402_bb0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijmm.2019.151359","article-title":"Allicin, a natural antimicrobial defence substance from garlic, inhibits DNA gyrase activity in bacteria","volume":"310","author":"Reiter","year":"2020","journal-title":"Int. J. Med. Microbiol."},{"key":"10.1016\/j.ijbiomac.2023.128402_bb0290","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ijmmb.2022.11.005","article-title":"India-discovered levonadifloxacin & alalevonadifloxacin: a review on susceptibility testing methods, CLSI quality control and breakpoints along with a brief account of their emerging therapeutic profile as a novel standard-of-care","volume":"41","author":"Veeraraghavan","year":"2022","journal-title":"Indian J. Med. Microbiol."},{"key":"10.1016\/j.ijbiomac.2023.128402_bb0295","doi-asserted-by":"crossref","first-page":"4351","DOI":"10.2147\/DDDT.S229882","article-title":"Levonadifloxacin, a novel broad-spectrum anti-MRSA benzoquinolizine quinolone agent: review of current evidence","author":"Bhagwat","year":"2019","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.ijbiomac.2023.128402_bb0300","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1093\/jac\/dkad060","article-title":"Gepotidacin: a novel, oral,\u2018first-in-class\u2019 triazaacenaphthylene antibiotic for the treatment of uncomplicated urinary tract infections and urogenital gonorrhoea","volume":"78","author":"Watkins","year":"2023","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ijbiomac.2023.128402_bb0305","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1021\/acsinfecdis.0c00021","article-title":"Zoliflodacin: an oral spiropyrimidinetrione antibiotic for the treatment of Neisseria gonorrheae, including multi-drug-resistant isolates","volume":"6","author":"Bradford","year":"2020","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.ijbiomac.2023.128402_bb0310","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S1473-3099(18)30614-5","article-title":"Cadazolid for the treatment of Clostridium difficile infection: results of two double-blind, placebo-controlled, non-inferiority, randomised phase 3 trials","volume":"19","author":"Gerding","year":"2019","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.ijbiomac.2023.128402_bb0315","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2021.128432","article-title":"Design and synthesis of an oral prodrug alalevonadifloxacin for the treatment of MRSA infection","volume":"54","author":"Bhawsar","year":"2021","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ijbiomac.2023.128402_bb0320","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/j.ejmech.2018.08.095","article-title":"Recent developments of quinolone-based derivatives and their activities against Escherichia coli","volume":"157","author":"Gao","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2023.128402_bb0325","doi-asserted-by":"crossref","DOI":"10.1016\/j.anaerobe.2021.102346","article-title":"In vivo pharmacodynamics of lascufloxacin and levofloxacin against Streptococcus pneumoniae and Prevotella intermedia in a pneumonia mixed-infection mouse model","volume":"69","author":"Hagihara","year":"2021","journal-title":"Anaerobe"},{"key":"10.1016\/j.ijbiomac.2023.128402_bb0330","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/s41591-022-02115-4","article-title":"Molecular residual disease and efficacy of adjuvant chemotherapy in patients with colorectal cancer","volume":"29","author":"Kotani","year":"2023","journal-title":"Nat. Med."},{"key":"10.1016\/j.ijbiomac.2023.128402_bb0335","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/j.jiac.2021.03.026","article-title":"In vitro activities and spectrum of lascufloxacin (KRP-AM1977) against anaerobes","volume":"27","author":"Tanaka","year":"2021","journal-title":"J. Infect. Chemother."},{"key":"10.1016\/j.ijbiomac.2023.128402_bb0340","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ijantimicag.2011.03.002","article-title":"Activity of finafloxacin, a novel fluoroquinolone with increased activity at acid pH, towards extracellular and intracellular Staphylococcus aureus, Listeria monocytogenes and Legionella pneumophila","volume":"38","author":"Lemaire","year":"2011","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.ijbiomac.2023.128402_bb0345","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1016\/j.tetlet.2009.03.051","article-title":"A novel approach to Finafloxacin hydrochloride (BAY35-3377)","volume":"50","author":"Hong","year":"2009","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.ijbiomac.2023.128402_bb0350","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.ijantimicag.2014.07.006","article-title":"Activity of the investigational fluoroquinolone finafloxacin and seven other antimicrobial agents against 114 obligately anaerobic bacteria","volume":"44","author":"Genzel","year":"2014","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.ijbiomac.2023.128402_bb0355","doi-asserted-by":"crossref","DOI":"10.1016\/j.diagmicrobio.2023.115946","article-title":"Analysis of the effect of urine on the in vitro activity of gepotidacin and levofloxacin against Escherichia coli, Staphylococcus epidermidis, and Staphylococcus saprophyticus","volume":"106","author":"Koeth","year":"2023","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"10.1016\/j.ijbiomac.2023.128402_bb0360","doi-asserted-by":"crossref","DOI":"10.1016\/j.diagmicrobio.2021.115484","article-title":"Analysis of antimicrobial susceptibility testing methods and variables and in vitro activity of gepotidacin against urogenital Neisseria gonorrhoeae in men","volume":"101","author":"Scangarella-Oman","year":"2021","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"10.1016\/j.ijbiomac.2023.128402_bb0365","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115413","article-title":"Antibiotics with novel mode of action as new weapons to fight antimicrobial resistance","author":"Ruggieri","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2023.128402_bb0370","doi-asserted-by":"crossref","first-page":"e247","DOI":"10.1016\/S2666-5247(22)00356-1","article-title":"Neisseria gonorrhoeae diagnostic escape from a gyrA-based test for ciprofloxacin susceptibility and the effect on zoliflodacin resistance: a bacterial genetics and experimental evolution study","volume":"4","author":"Rubin","year":"2023","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.ijbiomac.2023.128402_bb0375","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.jgar.2020.10.017","article-title":"Tentative clinical breakpoints and epidemiological cut-off values of nemonoxacin for Streptococcus pneumoniae and Staphylococcus aureus isolates associated with community-acquired pneumonia","volume":"23","author":"Jean","year":"2020","journal-title":"J. Glob. Antimicrob. Resist."},{"key":"10.1016\/j.ijbiomac.2023.128402_bb0380","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jmii.2017.07.011","article-title":"Safety and efficacy of oral nemonoxacin versus levofloxacin in treatment of community-acquired pneumonia: a phase 3, multicenter, randomized, double-blind, double-dummy, active-controlled, non-inferiority trial","volume":"52","author":"Yuan","year":"2019","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"10.1016\/j.ijbiomac.2023.128402_bb0385","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.ijantimicag.2010.12.003","article-title":"In vitro susceptibilities of clinical isolates of ertapenem-non-susceptible Enterobacteriaceae to nemonoxacin, tigecycline, fosfomycin and other antimicrobial agents","volume":"37","author":"Hsu","year":"2011","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.ijbiomac.2023.128402_bb0390","article-title":"Identification of micrococcin P2-derivatives as antibiotic candidates against two gram-positive pathogens","volume":"3","author":"Kim","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2023.128402_bb0395","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.medmal.2017.10.009","article-title":"Exploring ways to improve CDI outcomes","volume":"48","author":"Galp\u00e9rine","year":"2018","journal-title":"Med. Mal. Infect."},{"key":"10.1016\/j.ijbiomac.2023.128402_bb0400","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.anaerobe.2014.07.001","article-title":"In vitro activity of MCB3681 against Clostridium difficile strains","volume":"28","author":"Rashid","year":"2014","journal-title":"Anaerobe"},{"key":"10.1016\/j.ijbiomac.2023.128402_bb0405","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.anaerobe.2013.02.003","article-title":"In vitro activity of cadazolid against Clostridium difficile strains isolated from primary and recurrent infections in Stockholm, Sweden","volume":"20","author":"Rashid","year":"2013","journal-title":"Anaerobe"},{"key":"10.1016\/j.ijbiomac.2023.128402_bb0410","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.cmi.2017.12.022","article-title":"Update of treatment algorithms for Clostridium difficile infection","volume":"24","author":"Ooijevaar","year":"2018","journal-title":"Clin. Microbial. Infect."},{"key":"10.1016\/j.ijbiomac.2023.128402_bb0415","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3389\/fcimb.2018.00114","article-title":"Molecular targets related drug resistance mechanisms in MDR-, XDR-, and TDR-Mycobacterium tuberculosis strains","volume":"8","author":"Hameed","year":"2018","journal-title":"Front. Cell. Infect. Microbiol."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813023053011?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813023053011?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T10:58:12Z","timestamp":1758884292000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813023053011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":83,"alternative-id":["S0141813023053011"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2023.128402","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Schematic-portfolio of potent anti-microbial scaffolds targeting DNA gyrase: Unlocking ways to overcome resistance","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2023.128402","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"128402"}}